Paladin Labs
Pierre Morel has extensive work experience in research and development and project management. Pierre began their career as a Research Associate at McMaster University in 2002 before joining Jubilant DraxImage as a Senior Research Chemist. Pierre went on to hold various roles at Jubilant DraxImage, including Manager of Process Development and Senior Manager of R&D. In 2014, Pierre joined Héma-Québec as a Project Manager of Stem Cell Production. Most recently, they have been serving as the Director of R&D at Paladin Labs since 2015.
Pierre Morel completed their education history with a Post-Doc degree in Radiopharmaceutical Development from McMaster University in 2002. Prior to that, they obtained a Doctor of Philosophy (Ph.D.) in Inorganic Chemistry from Pierre and Marie Curie University from 1996 to 1999. Pierre also earned an Engineer's Degree in Chemical Engineering from Chimie ParisTech - PSL between 1993 and 1995.
This person is not in any offices
Paladin Labs
Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. Paladin has a focused marketing and sales organization that has helped it evolve into a well-known Canadian specialty pharmaceutical company with a breadth of products. Paladin is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.